Lapides Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Lapides Asset Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-38,700	Closed	-$552K	–	81
2016 Q2	$552K	Hold	38,700	–	–	0.1%	69
2016 Q1	$601K	Buy	38,700 +600	+2%	+$8.6K	0.11%	69
2015 Q4	$657K	Sell	38,100 -61,600	-62%	-$891K	0.12%	81
2015 Q3	$1.22M	Sell	99,700 -45,400	-31%	-$582K	0.21%	77
2015 Q2	$1.75M	Sell	145,100 -6,700	-4%	-$66K	0.28%	69
2015 Q1	$1.27M	Sell	151,800 -206,600	-58%	-$1.62M	0.21%	68
2014 Q4	$2.74M	Buy	358,400 +30,200	+9%	+$216K	0.37%	63
2014 Q3	$2.26M	Hold	328,200	–	–	0.32%	67
2014 Q2	$2.71M	Hold	328,200	–	–	0.37%	64
2014 Q1	$2.65M	Hold	328,200	–	–	0.37%	60
2013 Q4	$2.63M	Hold	328,200	–	–	0.36%	61
2013 Q3	$2.2M	Hold	328,200	–	–	0.29%	66
2013 Q2	$2.15M	Buy	+328,200	New	+$2.07M	0.31%	63

Other funds holding LMAT

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lapides Asset Management's LMAT Position: Q3 2016 in Review

Lapides Asset Management sold out of LeMaitre Vascular (LMAT) in Q3 2016, closing a stake of 38,700 shares — an estimated $552K sold.

Lapides Asset Management first reported a position in LMAT in Q2 2013 and held it in 13 quarters. The position peaked at $2.74M in Q4 2014. 111 funds tracked by Wall St. Rank hold LMAT as of Q3 2016.

Lapides Asset Management reported no remaining LeMaitre Vascular position as of Q3 2016 after selling out during the quarter.
Lapides Asset Management sold 38,700 LeMaitre Vascular shares in Q3 2016, an estimated $552K.
Lapides Asset Management first reported a position in LeMaitre Vascular in Q2 2013 and held it in 13 quarters.
Lapides Asset Management's LeMaitre Vascular position peaked at $2.74M in Q4 2014.
111 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2016.

Based on Lapides Asset Management's 13F filing for Q3 2016, filed 8 Nov 2016.